Presence of a p53 Gene Deletion in Patients With Multiple Myeloma Predicts for Short Survival After Conventional-Dose Chemotherapy
Johannes Drach(Vienna General Hospital), H. Huber(Munich University of Applied Sciences), Maria DeSantis(University of Vienna), Heinz Ludwig(Wilhelminen Hospital), Heinz Gisslinger(Medical University of Vienna), Elisabeth Krömer(University of Vienna), Niklas Zojer(University of Vienna), R. Roka(University of Vienna), E. Fritz(Unknown), Jutta Ackermann(University of Vienna), R. Heinz(University of Vienna), Michael Fiegl(University of Vienna), Rudolf Schuster(University of Vienna), J. C. Schuster(Wilhelminen Hospital)
Cited by 321
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k